Douglass Winthrop Advisors’s Quest Diagnostics DGX Stock Holding History

Douglass Winthrop Advisors’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$781K	Hold	3,686	–	–	0.01%	189
2026 Q1	$722K	Hold	3,686	–	–	0.01%	181
2025 Q4	$640K	Hold	3,686	–	–	0.01%	191
2025 Q3	$702K	Buy	3,686 +36	+1%	+$6.39K	0.01%	181
2025 Q2	$656K	Hold	3,650	–	–	0.01%	173
2025 Q1	$618K	Hold	3,650	–	–	0.01%	175
2024 Q4	$551K	Hold	3,650	–	–	0.01%	200
2024 Q3	$567K	Hold	3,650	–	–	0.01%	194
2024 Q2	$500K	Hold	3,650	–	–	0.01%	194
2024 Q1	$486K	Hold	3,650	–	–	0.01%	195
2023 Q4	$503K	Hold	3,650	–	–	0.01%	171
2023 Q3	$445K	Hold	3,650	–	–	0.01%	172
2023 Q2	$513K	Hold	3,650	–	–	0.01%	168
2023 Q1	$516K	Hold	3,650	–	–	0.01%	169
2022 Q4	$571K	Hold	3,650	–	–	0.02%	164
2022 Q3	$448K	Hold	3,650	–	–	0.01%	175
2022 Q2	$485K	Hold	3,650	–	–	0.01%	179
2022 Q1	$500K	Hold	3,650	–	–	0.01%	187
2021 Q4	$631K	Hold	3,650	–	–	0.01%	174
2021 Q3	$530K	Hold	3,650	–	–	0.01%	190
2021 Q2	$482K	Hold	3,650	–	–	0.01%	200
2021 Q1	$468K	Hold	3,650	–	–	0.01%	196
2020 Q4	$435K	Hold	3,650	–	–	0.01%	199
2020 Q3	$418K	Hold	3,650	–	–	0.01%	194
2020 Q2	$416K	Buy	+3,650	New	+$387K	0.02%	179
2018 Q3	–	Sell	-1,850	Closed	-$203K	–	261
2018 Q2	$203K	Buy	+1,850	New	+$193K	0.01%	278
2015 Q4	–	Sell	-3,350	Closed	-$206K	–	235
2015 Q3	$206K	Buy	+3,350	New	+$234K	0.02%	225

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Douglass Winthrop Advisors's DGX Position: Q2 2026 in Review

Douglass Winthrop Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 3,686 shares worth $781K. The position accounts for 0.01% of the portfolio, ranked #189.

Douglass Winthrop Advisors first reported a position in DGX in Q3 2015 and has held it in 27 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Douglass Winthrop Advisors held 3,686 shares of Quest Diagnostics worth $781K as of Q2 2026.
Douglass Winthrop Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.01% of Douglass Winthrop Advisors's portfolio in Q2 2026, its #189 holding.
Douglass Winthrop Advisors first reported a position in Quest Diagnostics in Q3 2015 and has held it in 27 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.